Biogen announces job cuts, turns focus to Alzheimer's drug launch
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Biogen (BIIB) tops earnings expectations, reveals workforce reduction
July 25, 2023 9:22 AM EDTBiogen (NASDAQ: BIIB) shares are trading higher premarket after topping second-quarter earnings and revenue expectations. The company also revealed it will cut jobs in order to save costs.
BIIB reported Q2 EPS of $4.02, $0.24 better than the analyst estimate of $3.78, while revenue for the quarter came... More

